Distinguished in Swallowing Difficulty

Dr. Michael Steinbook

Gastroenterology
Columbus Ambulatory Healthcare Services, Inc.
1800 10th Ave, 
Columbus, GA 
Offers Telehealth
Distinguished in Swallowing Difficulty
Columbus Ambulatory Healthcare Services, Inc.
1800 10th Ave, 
Columbus, GA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Michael Steinbook is a Gastroenterologist in Columbus, Georgia. Dr. Steinbook is rated as a Distinguished provider by MediFind in the treatment of Swallowing Difficulty. His top areas of expertise are Chronic Erosive Gastritis, Gastrointestinal Bleeding, Lower Esophageal Ring, Gastrectomy, and Gastrostomy.

His clinical research consists of participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Gastroenterology
Licenses
Internal Medicine in GA
Hospital Affiliations
Piedmont Columbus Regional Midtown
Piedmont Columbus Regional Northside
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Alliant Health
  • HMO
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Farm Bureau Health Plans
  • HMO
  • MEDICARE MAPD
  • MEDICARE PDP
Friday Health

Accepted plan types not found. Please verify directly with the provider.

Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 13 Less Insurance Carriers -

Locations

COLUMBUS AMBULATORY HEALTHCARE SERVICES, INC.
1800 10th Ave, Columbus, GA 31901
Other Locations
COLUMBUS AMBULATORY HEALTHCARE SERVICES, INC.
100 Frist Ct, Columbus, GA 31909
COLUMBUS AMBULATORY HEALTHCARE SERVICES, INC.
710 Ctr St, Columbus, GA 31901
COLUMBUS AMBULATORY HEALTHCARE SERVICES, INC.
1117 20th St, Columbus, GA 31901

Additional Areas of Focus

Dr. Steinbook has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Non-Alcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis (NASH)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active- Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Crohn's Disease
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active- Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Crohn's Disease
Enrollment Status: Completed
Publish Date: December 27, 2024
Intervention Type: Drug
Study Drugs: Mirikizumab, Ustekinumab
Study Phase: Phase 3
A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
Enrollment Status: Terminated
Publish Date: October 01, 2024
Intervention Type: Drug
Study Drug: Obeticholic Acid
Study Phase: Phase 3
A Phase 3 Long-term Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
A Phase 3 Long-term Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
Enrollment Status: Completed
Publish Date: June 21, 2024
Intervention Type: Drug
Study Drug: Ontamalimab
Study Phase: Phase 3
A Phase 2, Multicenter, Randomized, Parallel-Arm, Placebo-Controlled Study of LY3074828 in Subjects With Active Crohn's Disease (SERENITY)
A Phase 2, Multicenter, Randomized, Parallel-Arm, Placebo-Controlled Study of LY3074828 in Subjects With Active Crohn's Disease (SERENITY)
Enrollment Status: Completed
Publish Date: August 30, 2022
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 2
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 303)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 303)
Enrollment Status: Completed
Publish Date: January 14, 2022
Intervention Type: Other, Drug
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 301)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 301)
Enrollment Status: Terminated
Publish Date: June 14, 2021
Intervention Type: Other, Drug
Study Phase: Phase 3
A Phase 2, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Study of LY3074828 in Subjects With Moderate to Severe Ulcerative Colitis
A Phase 2, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Study of LY3074828 in Subjects With Moderate to Severe Ulcerative Colitis
Enrollment Status: Completed
Publish Date: June 17, 2020
Intervention Type: Drug
Study Phase: Phase 2
View 6 Less Clinical Trials
Similar Doctors
Distinguished in Swallowing Difficulty
Dr. Layth Saymeh
Gastroenterology
Distinguished in Swallowing Difficulty
Dr. Layth Saymeh
Gastroenterology

Phoebe Physician Group Inc

151 Mayo St, Suite B, 
Americus, GA 
 (52.4 miles away)
229-928-2900
Languages Spoken:
English
See accepted insurances

Layth Saymeh is a Gastroenterologist in Americus, Georgia. Dr. Saymeh is rated as a Distinguished provider by MediFind in the treatment of Swallowing Difficulty. His top areas of expertise are Chronic Erosive Gastritis, Gastroesophageal Reflux Disease (GERD), Gastritis, Gastrectomy, and Endoscopy.

Distinguished in Swallowing Difficulty
Dr. Pravinchandra Patel
Gastroenterology
Distinguished in Swallowing Difficulty
Dr. Pravinchandra Patel
Gastroenterology

Gastrointestinal Diseases Inc

1130 Talbotton Rd, 
Columbus, GA 
 (0.4 miles away)
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Pravinchandra Patel is a Gastroenterologist in Columbus, Georgia. Dr. Patel is rated as a Distinguished provider by MediFind in the treatment of Swallowing Difficulty. His top areas of expertise are Gastroesophageal Reflux Disease (GERD), Chronic Erosive Gastritis, Swallowing Difficulty, Endoscopy, and Gastrostomy.

Distinguished in Swallowing Difficulty
Dr. Shankar Thiruppathi
Gastroenterology
Distinguished in Swallowing Difficulty
Dr. Shankar Thiruppathi
Gastroenterology

Gastrointestinal Diseases Inc

1130 Talbotton Rd, 
Columbus, GA 
 (0.4 miles away)
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Shankar Thiruppathi is a Gastroenterologist in Columbus, Georgia. Dr. Thiruppathi is rated as a Distinguished provider by MediFind in the treatment of Swallowing Difficulty. His top areas of expertise are Gastroesophageal Reflux Disease (GERD), Chronic Erosive Gastritis, Lower Esophageal Ring, Endoscopy, and Gastrostomy.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Steinbook's expertise for a condition
ConditionClose
    View All 12 Distinguished Conditions
    View All 27 Advanced Conditions
    View All 59 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile